Please login to the form below

Not currently logged in
Email:
Password:

Federal Trade Commission

This page shows the latest Federal Trade Commission news and features for those working in and with pharma, biotech and healthcare.

UK’s Competition and Markets Authority to review AZ/Alexion merger

UK’s Competition and Markets Authority to review AZ/Alexion merger

While the CMA has announced its intention to scrutinise the deal, the US Federal Trade Commission (FTC) has already cleared the proposed acquisition.

Latest news

More from news
Approximately 3 fully matching, plus 66 partially matching documents found.

Latest Intelligence

  • Will biosimilars ever catch on in the US? Will biosimilars ever catch on in the US?

    The Federal Trade Commission (FTC), which has broad powers to regulate business practices, estimates these anti-competitive deals cost consumers $3.5bn a year, and they delay the availability of ... New and complex. In his BAP remarks, Gottlieb said the

  • Innovation in merger control and the impact on the pharmaceutical sector Innovation in merger control and the impact on the pharmaceutical sector

    Pipeline problems. The Commission’s novel approach has its roots in pharma mergers. ... In the US, the Federal Trade Commission (FTC) has followed a similar approach.

  • Deal Watch June 2016 Deal Watch June 2016

    Three of the deals were focused on the requirement of Teva and Allergan to divest assets to satisfy the regulators and obtain clearance from the US Federal Trade Commission for

  • Pharma deals in May 2015 Pharma deals in May 2015

    The product has been the subject of an investigation from the US Federal Trade Commission (FTC) and although not usually reported in Deal Watch, the $1.2bn settlement is noteworthy recognising ... Watch this space! PRVs. Finally, we noted in the Annual

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
The Good Ideas Group

Remarkable but responsible creative work. We're most passionate about the pursuit of original, powerful ideas that our clients can harness...

Latest intelligence

Committing time to making meaningful connections - top 5 tips
Read the second blog of the series looking at key barriers to effective patient engagement in pharma...
News:
Senior Analytics Specialist joins Research Partnership...
Digital technologies: Pharma’s answer to achieving net zero emissions?
...